Reuters - FCC majority backs Charter purchase of Time Warner Cabl

Reuters
FCC majority backs Charter purchase of Time Warner Cable

WASHINGTON (Reuters) - A majority of the five-member U.S. Federal Communications Commission has voted to approve Charter Communications Inc (CHTR.O) acquisition of Time Warner Cable Inc (TWC.N) and Bright House networks, which would create the second-largest U.S. broadband provider and third-largest video provider, two sources briefed on the matter said Thursday.

FCC Commissioners Jessica Rosenworcel and Michael O'Rielly earlier this week joined FCC chairman Tom Wheeler in voting to approve the deals, the sources said. O'Rielly dissented in part, meaning the final conditions of the approval could change before the full vote is completed and made public. The U.S. Justice Department approved the acquisitions with conditions on April 25.

The Evonomist : China : The coming debt bust


The coming debt bust
It is a question of when, not if, real trouble will hit in China
May 7th 2016

CHINA was right to turn on the credit taps to prop up growth after the global financial crisis. It was wrong not to turn them off again. The country’s debt has increased just as quickly over the past two years as in the two years after the 2008 crunch. Its debt-to-GDP ratio has soared from 150% to nearly 260% over a decade, the kind of surge that is usually followed by a financial bust or an abrupt slowdown.
China will not be an exception to that rule. Problem loans have doubled in two years and, officially, are already 5.5% of banks’ total lending. The reality is grimmer. Roughly two-fifths of new debt is swallowed by interest on existing loans; in 2014, 16% of the 1,000 biggest Chinese firms owed more in interest than they earned before tax. China requires more and more credit to generate less and less growth: it now takes nearly four yuan of new borrowing to generate one yuan of additional GDP, up from just over one yuan of credit before the financial crisis. With the government’s connivance, debt levels can probably keep climbing for a while, perhaps even for a few more years. But not for ever.
Advertisement

When the debt cycle turns, both asset prices and the real economy will be in for a shock. That won’t be fun for anyone. It is true that China has been fastidious in capping its external liabilities (it is a net creditor). Its dangers are home-made. But the damage from a big Chinese credit blow-up would still be immense. China is the world’s second-biggest economy; its banking sector is the biggest, with assets equivalent to 40% of global GDP. Its stockmarkets, even after last year’s crash, are together worth $6 trillion, second only to America’s. And its bond market, at $7.5 trillion, is the world’s third-biggest and growing fast. A mere 2% devaluation of the yuan last summer sent global stockmarkets crashing; a bigger bust would do far worse. A mild economic slowdown caused trouble for commodity exporters around the world; a hard landing would be painful for all those who benefit from Chinese demand.
Brace, brace
Optimists have drawn comfort from two ideas. First, over three-plus decades of reform, China’s officials have consistently shown that once they identified problems, they had the will and skill to fix them. Second, control of the financial system—the state owns the major banks and most of their biggest debtors—gave them time to clean things up.
Both these sources of comfort are fading away. This is a government not so much guiding events as struggling to keep up with them. In the past year alone, China has spent nearly $200 billion to prop up the stockmarket; $65 billion of bank loans have gone bad; financial frauds have cost investors at least $20 billion; and $600 billion of capital has left the country. To help pump up growth, officials have inflated a property bubble. Debt is still expanding twice as fast as the economy.
At the same time, as our special report this week shows, the government’s grip on finance is slipping. Despite repeated efforts to restrain them, loosely regulated forms of lending are growing quickly: such “shadow assets” have increased by more than 30% annually over the past three years. In theory, shadow banks diversify sources of credit and spread risk away from the regular banks. In practice, the lines between the shadow and formal banking systems are badly blurred.
That creates two risks. The first is higher-than-expected losses for the banks. Hungry for profits in a slowing economy, plenty of Chinese banks have mis-categorised risky loans as investments to dodge scrutiny and lessen capital requirements. These shadow loans were worth roughly 16% of standard loans in mid-2015, up from just 4% in 2012. The second risk is liquidity. The banks have become ever more reliant on “wealth management products”, whereby they pay higher rates for what are, in effect, short-term deposits and put them into longer-term assets. For years China restricted bank loans to less than 75% of their deposit base, ensuring that they had plenty of cash in reserve. Now the real level is nearing 100%, a threshold where a sudden shortage in funding—the classic precursor to banking crises—is well within the realm of possibility. Midsized banks have been the most active in expanding; they are the place to look for sudden trouble.
Pandamonium
The end to China’s debt build-up would not look exactly like past financial blow-ups. China’s shadow-banking system is big, but it has not spawned any products nearly as complex or international in reach as America’s bundles of subprime mortgages in 2008. Its relatively insulated financial system means that parallels with the 1997-98 Asian crisis, in which countries from Thailand to South Korea borrowed too much from abroad, are thin. Some worry that China will look like Japan in the 1990s, slowly grinding towards stagnation. But its financial system is more chaotic, with more pressure for capital outflows, than was Japan’s; a Chinese crisis is likely to be sharper and more sudden than Japan’s chronic malaise.
One thing is certain. The longer China delays a reckoning with its problems, the more severe the eventual consequences will be. For a start, it should plan for turmoil. Policy co-ordination was appalling during last year’s stockmarket crash; regulators must work out in advance who monitors what and prepare emergency responses. Rather than deploying both fiscal and monetary stimulus to keep growth above the official target of at least 6.5% this year (which is, in any event, unnecessarily fast), the government should save its firepower for a real calamity. The central bank should also put on ice its plans to internationalise the yuan; a premature opening of the capital account would lead only to big outflows and bigger trouble, when the financial system is already on shaky ground.
Most important, China must start to curb the relentless rise of debt. The assumption that the government of Xi Jinping will keep bailing out its banks, borrowers and depositors is pervasive—and not just in China itself. It must tolerate more defaults, close failed companies and let growth sag. This will be tough, but it is too late for China to avoid pain. The task now is to avert something far worse.
Be the first to comment

>>> Sanofi tells Medivation it could be in position to revise offer

Sanofi tells Medivation it could be in position to revise offer

Sanofi [EPA:SAN] today sent a letter to Medivation's [NASDAQ: MDVN] board reiterating its preference to engage in negotiations, saying it could be in a position to revise its offer if Medivation engages in good faith discussions.

Letter:

Dear Members of the Board of Directors,

Since we publicly disclosed our proposal to acquire Medivation, we have had extensive conversations with your top shareholders. We believe there is overwhelming support by your shareholders for a transaction. Absent our proposal, we believe that the Medivation shares would be trading in the $30's. Medivation traded at $27 per share less than three months ago, and our proposal is almost a 100% premium to that price. It is over a 50% premium to average trading prices prior to there being takeover rumors.

I want to reiterate our preference to engage with you to negotiate a transaction. We believe immediate engagement would be in the best interests of your shareholders as it would enable them promptly to realize substantial and certain value, while minimizing the disruption to your organization. We believe we have offered a fair price, and a very attractive premium. Nothing in your press release rejecting our proposal was new information to the market. Having said that, if you engage in good faith discussions with us and demonstrate additional value, we could be in a position to revise our offer.

You should know that an acquisition of Medivation is a priority for Sanofi and we are committed to effecting it. If you are not prepared to engage with us, we have no choice but to go directly to your shareholders. As you know, your shareholders have the ability to act at any time by written consent to remove and replace the Board. If the Medivation Board of Directors continues to refuse to engage with us, then we intend to commence a process to remove and replace members of the Board.

We remain enthusiastic about a potential combination with Medivation. We and our advisors stand ready to meet at any time so we can work to quickly consummate a mutually beneficial transaction.

Sincerely,


Olivier Brandicourt
Chief Executive Officer

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: RRTS -26.4%, TCAP -17.1%, KTOS -12.3%, SQNM -11.1%, FIT -11.1%, WTI -9.9%, ALIM -9.5%, DPM -8.2%, ABC -7.5%, WFT -7.4%, CTL -4.7%, EXEL -4.6%, PSXP -4.4%, AVP -4.4%, HRTG -4.2%, NWPX -4.2%, HRTG -4.2%, OSUR -4.1%, SRPT -3.9%, LNC -3.8%, LPSN -3.8%, TRIP -3.1%, SNN -3.1%, CTLT -2.6%, MUR -2.5%, BRKR -2.4%, MET -2.1%, SEAS -2%, PRU -1.7%, ALJ -1.7%, ERII -1.7%, NVAX -1.5%, HUBS -1.5%, LUK -1.5%, OME -1.4%, (announces $40 mln share repurchase program, moves forward with previously announced $18 mln investment in the animal nutrition biz (), WMB -1.2%, TNH -0.9%, RDUS -0.7%, GWPH -0.7%, BLUE -0.6%

Other news: PSXP -3.8% (commences 7.5 mln offering of common units representing limited partner interests in the Partnership), ADC -2.9% (upsizes & prices 2.5 mln share common stock offering for gross proceeds of ~$99.4 mln), STI -1.6% (receives subpoena in relation to embezzlement by an employee of a SunTrust business client), CAT -0.9% (Greenlight's David Einhorn announces at Ira Sohn that he is Short CAT )

Analyst comments: CRUS -3.2% (downgraded to Equal Weight from Overweight at Barclays), GOLD -1.2% (downgraded to Sell from Neutral at Citigroup) 

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance: LGCY +26.5%, EPE +18.8%, WTW+14.2%, ZNGA +13%, LHCG +9.2%, AVID +8.9%, GSS +8.3%, ARRS +8.1%, DNR+8%, GPL +7%, HDSN +6.9%, BNFT +6.7%, NRG +6.6%, QRVO +6.3%, NEWT +6%,SZYM +5.9%, KHC +5.7%, ETE +5.3%, BABA +4.9%, AUY +4.7%, CECO +4.4%, +4.4%, AXGN +4.3%, TSLA +4%, CLR +4%, ORA +3.9%, MTW +3.9%, WBMD+3.8%, CSOD +3.5%, MRO +3.4%, KND +3.4%, BT +3.4%, DOOR +3.2%, RIG+3.1%, AREX +2.8%, CF +2.8%, NICE +2.8%, GIL +2.7%, (Ennis accepts a superior offer to sell its apparel division to Gildan Activewear (GIL) for $110 mln in cash), TASR +2.6%, TASR +2.6%, CBMX +2.5%, TDC +2.5%, FIG +2.5%, GORO+2.4%, RLYP +2.2%, TWO +2.2%, PAGP +2.1%, CB +1.9%, CATO +1.9%, ALDW+1.6%, STOR +1.5%, MBLY +1.3%, AG +1.3%, MCK +1.2%, CENT +1.2%, OREX+1.1%, LXP +1.1%, OXY +1%, EQIX +0.9%, CBPO +0.8%, JONE +0.7%, WFM+0.5%, HL +0.5%
M&A news: ZPIN +9.6% (receives non-binding proposal letter to be taken private), TPUB +4.4% (Tribune Publishing Board sends letter rejecting Gannett's (GCI) acquisition proposal at $12.25/share in cash, also reported earnings), BMI+2.2% (confirms it is exploring on a preliminary basis various options to enhance shareholder value)


Other news: SYNC +144.7% (awarded contract from AT&T, also reported earnings), FCEL +21% (FuelCell Energy and Exxon (XOM) announce an agreement to pursue novel technology in power plant carbon dioxide capture through a new application of carbonate fuel cells), CNAT +16.2% (Conatus Pharma announces 'positive' top-line results from the three-month, open-label second stage ofits multicenter Phase 2 clinical trial of emricasan in patients with liver cirrhosis ),UNXL +11.7% (announces the addition of a new customer with design wins for two new notebooks featuring itsXTouch and Diamond Guard technologies), SGYP+7.9% (commences ~29.95 mln registered direct common stock offering with certain investors at $3.00/share), RWLK +6.6% (announces that the US Dept of VA has purchased an additional 20 ReWalk Personal Systems to 'support initiation' of their national clinical trial ), YHOO +3.9% (trading higher in sympathy with BABA), GM +1.7% (Greenlight's Einhorn reiterates positive stance on GM at Ira Sohn), MYL +1.1% (announces the U.S. launch of Hydralazine Hydrochloride Injection), VRX +1.1% (Valeant Pharma and IBM (IBM) announce a collaboration to develop an iPhone/iPad app to assist surgeons who perform cataract surgery)

Analyst comments: BHP +1.7% (upgraded to Equal Weight from Underweight at Barclays), XL +1.1% (upgraded to Hold from Sell at Deutsche Bank)

>>> Farfetch closes USD 110m funding round - ADVISORY COVERAGE (CORRECTION)

Farfetch closes USD 110m funding round - ADVISORY COVERAGE (CORRECTION)

Farfetch, an online marketplace for luxury goods and beauty products, announced today that it has received EUR 110m in investment from a pool of investors led by Temasek, which includes IDG and Eurazeo.

The company was advised by Qatalyst Partners (financial) and Taylor Wessing (legal).

Temasek was advised by Wealth X (financial), Slaughter & May (legal), and Deloitte (accountancy).

IDG was advised by Charles Russell Speechlys (legal) and EY (accountancy).

Eurazeo was advised by Dechert (legal).

FT : Rolls-Royce warns of ‘challenging’ 2016

Rolls-Royce warns of ‘challenging’ 2016

Shares in Rolls-Royce fell almost 5 per cent on Thursday after the UK engineering company warned “2016 continues to be a challenging year overall”.
Although Rolls-Royce stuck to its existing profit guidance for 2016, some analysts highlighted that the company is now counting on a strong performance in the second half of the year to offset a weak first half.

Rolls-Royce has issued five profit warnings since February 2014, because of problems at its civil aerospace, defence and marine businesses. Warren East, chief executive since July 2015, has embarked on a major restructuring to improve efficiency.
Speaking before Rolls-Royce’s annual meeting on Thursday, Mr East said: “Despite steady market conditions for most of our businesses, 2016 continues to be a challenging year overall as we sustain investment and start to transition major products in civil aerospace, and tackle weak markets in marine.”
He added trading so far this year was in line with the company’s expectations.
In late morning trading, Rolls-Royce’s shares were down almost 5 per cent at 613p.
The downturn in the oil and gas sector because of the plunge in crude prices since mid-2014 has undermined demand from the offshore energy industry for Rolls-Royce’s engines.
The company is also contending with a tricky transition from current to next generation engines used in passenger jets made by Airbus and Boeing.
In its last profit warning, Rolls-Royce in November alerted investors to a £650m hit to its 2016 earnings due to certain negative factors, including how airlines were retiring older jets that had its engines installed on them.
On Thursday the company said its profit before finance charges and tax for 2016 would be “significantly weighted towards the second half, with the first six months of the year expected to be close to break-even”.
“Looking to the balance of the year, the second half outlook reflects increased large [jet] engine deliveries, good underlying growth in after-market [service] revenues and expected incremental benefits from our ongoing restructuring programmes,” it added.

Rolls-Royce said it was on track to deliver cost savings of between £30m and £50m this year.
Nick Cunningham, analyst at Agency Partner, said: “The weak first half leaves a lot to do in [the second half], especially in challenging conditions and visibility is limited in some of the segments (eg marine and power, civil engines to some extent).”
Rob Stallard, analyst at RBC Capital Markets, said: “Rolls normally has a heavy weighting to the second half in its results, though the scale of the 2016 skew is particularly stark. Nothing in [first half] — everything in [second half].”